Safal Shetty on Building a Continuous Culture of Stroke Awareness at KIMS
Safal Shetty, Interventional Neurologist at Krishna Institute of Medical Sciences, shared on LinkedIn:
”Stroke prevention and treatment demand a comprehensive, year-round effort that involves everyone—from the public to frontline healthcare providers.
At Krishna Institute of Medical Sciences (KIMS) -MDP we are committed to raising stroke awareness across all levels.
Public education initiatives such as Cyclathon organised at our center focus on recognizing stroke symptoms early, understanding risk factors, and promoting healthy lifestyle changes to prevent stroke before it happens.
Equally important is empowering healthcare teams.
We provide continuous training for nurses, emergency doctors, and paramedics to ensure rapid identification, streamlined triage, and effective acute stroke management.
Our state-of-the-art cath lab enables timely interventions, such as mechanical thrombectomy, to restore blood flow and minimize brain injury.
This multidisciplinary, ongoing approach ensures that every stroke patient receives the best chance for recovery—from prevention and early recognition to advanced emergency care and rehabilitation.
Stroke awareness and treatment are not seasonal efforts—they are a constant commitment to saving lives and improving outcomes.”
Stay updated with Hemostasis Today.
-
Mar 13, 2026, 10:08Jack Hadfield: An Important Step Toward Finding Measurable Biology in Long COVID
-
Mar 13, 2026, 10:00Mandy Lauw: Can Reduced-Dose DOACs Be Applied to All Patients With VTE?
-
Mar 12, 2026, 20:44Honoring Marion Stolte’s Lasting Impact on the Bleeding Disorders Community – WFH
-
Mar 12, 2026, 20:37Paul Riley: Is Thrombin Generation Assay Ready for Prime Time?
-
Mar 12, 2026, 20:28Rob Maloney: Building Visibility for Bleeding Disorders in Rural Georgia
-
Mar 12, 2026, 20:19Akshat Jain: Validating Oral Pain Medication Use as a Global Marker in Sickle Cell Disease
-
Mar 12, 2026, 20:13Michael Makris: Early Clinical Results of AAV8-BDD FVIII Gene Therapy in Hemophilia A
-
Mar 12, 2026, 20:02Wolfgang Miesbach: From Heparin to Vaccines – The Expanding Biology of Anti-PF4 Immunothrombosis
-
Mar 12, 2026, 19:56Christophe Dubois: Celebrating Nicolas Gendron’s HDR Defense and Future in Hemostasis